Pajzsmirigymüködés súlyos nem-pajzsmirigy eredetü betegségekben.

Translated title of the contribution: Thyroid function in severe non-thyroidal diseases

J. Földes, G. Váradi, P. Lakatos, C. Bános, G. Tarján

Research output: Contribution to journalArticle

Abstract

The aim of the present study was to find out whether a change in the function of the pituitary-thyroid axis can be revealed in a relatively homogenous group of hematological patients. To clarify this problem serum levels of total-thyroxine and triidothyronine, free-thyroxine and free-triiodothyronine, reverse-triidothyronine and thyrotropin were detected in these patients. The majority of subjects with chronic myelogenous leukemia (in the remission phase) have normal pituitary-thyroid function, however a change in the peripheral metabolism of thyroxine can be revealed. Longitudinal studies in patients with acute myelogenous leukemia indicate that in some cases with the progression of the disease serum TSH and thyroid hormone levels decrease referring to secondary hypothyroidism and in these cases the measurement of serum free-thyroxine content by an analogue tracer method is not recommended. On the basis of the investigational results it is stated that in hematological patients the pituitary-thyroid function is influenced by the phase of illness and by the results of the given treatment.

Original languageHungarian
Pages (from-to)2415-2418
Number of pages4
JournalOrvosi Hetilap
Volume130
Issue number45
Publication statusPublished - Nov 5 1989

Fingerprint

Thyroxine
Thyroid Gland
Serum
Reverse Triiodothyronine
Thyrotropin
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Hypothyroidism
Thyroid Hormones
Acute Myeloid Leukemia
Longitudinal Studies
Disease Progression
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Földes, J., Váradi, G., Lakatos, P., Bános, C., & Tarján, G. (1989). Pajzsmirigymüködés súlyos nem-pajzsmirigy eredetü betegségekben. Orvosi Hetilap, 130(45), 2415-2418.

Pajzsmirigymüködés súlyos nem-pajzsmirigy eredetü betegségekben. / Földes, J.; Váradi, G.; Lakatos, P.; Bános, C.; Tarján, G.

In: Orvosi Hetilap, Vol. 130, No. 45, 05.11.1989, p. 2415-2418.

Research output: Contribution to journalArticle

Földes, J, Váradi, G, Lakatos, P, Bános, C & Tarján, G 1989, 'Pajzsmirigymüködés súlyos nem-pajzsmirigy eredetü betegségekben.', Orvosi Hetilap, vol. 130, no. 45, pp. 2415-2418.
Földes J, Váradi G, Lakatos P, Bános C, Tarján G. Pajzsmirigymüködés súlyos nem-pajzsmirigy eredetü betegségekben. Orvosi Hetilap. 1989 Nov 5;130(45):2415-2418.
Földes, J. ; Váradi, G. ; Lakatos, P. ; Bános, C. ; Tarján, G. / Pajzsmirigymüködés súlyos nem-pajzsmirigy eredetü betegségekben. In: Orvosi Hetilap. 1989 ; Vol. 130, No. 45. pp. 2415-2418.
@article{bc9324fa61844517a190bf9bc26675d6,
title = "Pajzsmirigym{\"u}k{\"o}d{\'e}s s{\'u}lyos nem-pajzsmirigy eredet{\"u} betegs{\'e}gekben.",
abstract = "The aim of the present study was to find out whether a change in the function of the pituitary-thyroid axis can be revealed in a relatively homogenous group of hematological patients. To clarify this problem serum levels of total-thyroxine and triidothyronine, free-thyroxine and free-triiodothyronine, reverse-triidothyronine and thyrotropin were detected in these patients. The majority of subjects with chronic myelogenous leukemia (in the remission phase) have normal pituitary-thyroid function, however a change in the peripheral metabolism of thyroxine can be revealed. Longitudinal studies in patients with acute myelogenous leukemia indicate that in some cases with the progression of the disease serum TSH and thyroid hormone levels decrease referring to secondary hypothyroidism and in these cases the measurement of serum free-thyroxine content by an analogue tracer method is not recommended. On the basis of the investigational results it is stated that in hematological patients the pituitary-thyroid function is influenced by the phase of illness and by the results of the given treatment.",
author = "J. F{\"o}ldes and G. V{\'a}radi and P. Lakatos and C. B{\'a}nos and G. Tarj{\'a}n",
year = "1989",
month = "11",
day = "5",
language = "Hungarian",
volume = "130",
pages = "2415--2418",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "45",

}

TY - JOUR

T1 - Pajzsmirigymüködés súlyos nem-pajzsmirigy eredetü betegségekben.

AU - Földes, J.

AU - Váradi, G.

AU - Lakatos, P.

AU - Bános, C.

AU - Tarján, G.

PY - 1989/11/5

Y1 - 1989/11/5

N2 - The aim of the present study was to find out whether a change in the function of the pituitary-thyroid axis can be revealed in a relatively homogenous group of hematological patients. To clarify this problem serum levels of total-thyroxine and triidothyronine, free-thyroxine and free-triiodothyronine, reverse-triidothyronine and thyrotropin were detected in these patients. The majority of subjects with chronic myelogenous leukemia (in the remission phase) have normal pituitary-thyroid function, however a change in the peripheral metabolism of thyroxine can be revealed. Longitudinal studies in patients with acute myelogenous leukemia indicate that in some cases with the progression of the disease serum TSH and thyroid hormone levels decrease referring to secondary hypothyroidism and in these cases the measurement of serum free-thyroxine content by an analogue tracer method is not recommended. On the basis of the investigational results it is stated that in hematological patients the pituitary-thyroid function is influenced by the phase of illness and by the results of the given treatment.

AB - The aim of the present study was to find out whether a change in the function of the pituitary-thyroid axis can be revealed in a relatively homogenous group of hematological patients. To clarify this problem serum levels of total-thyroxine and triidothyronine, free-thyroxine and free-triiodothyronine, reverse-triidothyronine and thyrotropin were detected in these patients. The majority of subjects with chronic myelogenous leukemia (in the remission phase) have normal pituitary-thyroid function, however a change in the peripheral metabolism of thyroxine can be revealed. Longitudinal studies in patients with acute myelogenous leukemia indicate that in some cases with the progression of the disease serum TSH and thyroid hormone levels decrease referring to secondary hypothyroidism and in these cases the measurement of serum free-thyroxine content by an analogue tracer method is not recommended. On the basis of the investigational results it is stated that in hematological patients the pituitary-thyroid function is influenced by the phase of illness and by the results of the given treatment.

UR - http://www.scopus.com/inward/record.url?scp=17144446166&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144446166&partnerID=8YFLogxK

M3 - Article

C2 - 2694058

AN - SCOPUS:17144446166

VL - 130

SP - 2415

EP - 2418

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 45

ER -